SI
EHC icon

Sapience Investments’s Encompass Health EHC Stock Holding History

Sapience Investments’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.61K Sell
27
-3,769
-99% -$387K 0.34% 93
2025
Q4 		$403K Sell
3,796
-2
-0.1% -$232 1.52% 43
2025
Q3 		$482K Sell
3,798
-5
-0.1% -$595 1.89% 34
2025
Q2 		$466K Sell
3,803
-1,120
-23% -$128K 0.31% 85
2025
Q1 		$499K Sell
4,923
-1,178
-19% -$115K 0.36% 74
2024
Q4 		$563K Sell
6,101
-1,885
-24% -$185K 0.33% 67
2024
Q3 		$772K Hold
7,986
– – 0.38% 68
2024
Q2 		$685K Sell
7,986
-1,209
-13% -$101K 0.35% 66
2024
Q1 		$759K Sell
9,195
-576
-6% -$42.2K 0.25% 65
2023
Q4 		$652K Hold
9,771
– – 0.16% 65
2023
Q3 		$656K Sell
9,771
-1,805
-16% -$124K 0.16% 60
2023
Q2 		$784K Sell
11,576
-5,253
-31% -$329K 0.18% 58
2023
Q1 		$910K Hold
16,829
– – 0.21% 56
2022
Q4 		$1.01M Hold
16,829
– – 0.21% 58
2022
Q3 		$761K Sell
16,829
-2,148
-11% -$107K 0.16% 63
2022
Q2 		$846K Sell
18,977
-2,237
-11% -$115K 0.16% 68
2022
Q1 		$1.2M Buy
21,214
+25
+0.1% +$1.3K 0.15% 70
2021
Q4 		$1.1M Buy
21,189
+4,488
+27% +$232K 0.13% 70
2021
Q3 		$997K Hold
16,701
– – 0.12% 73
2021
Q2 		$1.04M Sell
16,701
-2,419
-13% -$161K 0.13% 70
2021
Q1 		$1.25M Buy
19,120
+2,201
+13% +$144K 0.16% 69
2020
Q4 		$1.11M Sell
16,919
-32,833
-66% -$1.93M 0.15% 68
2020
Q3 		$2.57M Sell
49,752
-3,520
-7% -$181K 0.46% 67
2020
Q2 		$2.63M Sell
53,272
-9,628
-15% -$520K 0.48% 70
2020
Q1 		$3.2M Sell
62,900
-855
-1% -$49.3K 0.71% 62
2019
Q4 		$3.51M Sell
63,755
-126
-0.2% -$6.84K 0.49% 62
2019
Q3 		$3.22M Buy
63,881
+352
+0.6% +$17.7K 0.45% 72
2019
Q2 		$3.2M Buy
+63,529
New +$3.08M 0.44% 72
2017
Q2 		– Sell
-256,955
Closed -$8.75M – 83
2017
Q1 		$8.75M Buy
256,955
+120,620
+88% +$3.96M 1.43% 37
2016
Q4 		$4.47M Buy
+136,335
New +$4.42M 1.37% 43

Other funds holding EHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Sapience Investments's EHC Position: Q1 2026 in Review

Sapience Investments reduced its Encompass Health (EHC) stake by 99% in Q1 2026, selling an estimated $387K and leaving 27 shares worth $2.61K. The position accounts for 0.34% of the portfolio, ranked #93.

Sapience Investments first reported a position in EHC in Q4 2016 and has held it in 30 quarters since. The position peaked at $8.75M in Q1 2017. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Sapience Investments held 27 shares of Encompass Health worth $2.61K as of Q1 2026.
  • Sapience Investments sold 3,769 Encompass Health shares in Q1 2026, an estimated $387K.
  • Encompass Health made up 0.34% of Sapience Investments's portfolio in Q1 2026, its #93 holding.
  • Sapience Investments first reported a position in Encompass Health in Q4 2016 and has held it in 30 quarters since.
  • Sapience Investments's Encompass Health position peaked at $8.75M in Q1 2017.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Sapience Investments's 13F filing for Q1 2026, filed 15 May 2026.